| 000 | 01791 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515092953.0 | ||
| 264 | 0 | _c20071123 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a1095-9203 | ||
| 024 | 7 |
_a10.1126/science.1146317 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMenuz, Karen | |
| 245 | 0 | 0 |
_aTARP auxiliary subunits switch AMPA receptor antagonists into partial agonists. _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _cNov 2007 |
||
| 300 |
_a815-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a6-Cyano-7-nitroquinoxaline-2,3-dione _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzodiazepines _xpharmacology |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCerebellum _xcytology |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aDrug Partial Agonism |
| 650 | 0 | 4 |
_aHippocampus _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInterneurons _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aProtein Subunits _xphysiology |
| 650 | 0 | 4 |
_aPyramidal Cells _xdrug effects |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, AMPA _xagonists |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
| 650 | 0 | 4 |
_aTrichlormethiazide _xpharmacology |
| 700 | 1 | _aStroud, Robert M | |
| 700 | 1 | _aNicoll, Roger A | |
| 700 | 1 | _aHays, Franklin A | |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 318 _gno. 5851 _gp. 815-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.1146317 _zAvailable from publisher's website |
| 999 |
_c17493436 _d17493436 |
||